DaVita Venture Group (DVG) is the corporate venture capital arm of DaVita, a leading kidney care provider. It invests in, develops, and incubates companies and products that improve care for patients with kidney disease and related conditions, with a focus on digital health, pharmaceuticals, medical devices, and care delivery models.
38% of their portfolio is in Healthcare. Deal activity increased 200% year-over-year (3 deals in the last 12 months). Average disclosed round size is $59.5M (across 12 rounds with reported amounts).
Portfolio
11
Fund Size
—
Top Stage
Series B
Last 12 Mo
3
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
13 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 R1 Therapeutics | Series A | $77.5M | Mar 2026 |
 Greater Good Health | Debt | $20.5M | Mar 2026 |
| EElara Caring | Unknown | — | Feb 2026 |
| R1 Therapeutics | Series A | $77.5M | Jan 2026 |
 eGenesis | Series D | $191M | Aug 2025 |
| PPathalys Pharma | Series B | $105M | Aug 2024 |
 Pathalys | Growth | $150M | Jan 2023 |
| CConsejoSano | Series B | $17M | Dec 2020 |
 Wellth | Series A | $10M | May 2020 |
 Heartbeat | Series B | $20M | — |
 Dock Health | Seed | $5M | — |
| HHeartbeat Health | Series B | $20M | — |
| Greater Good Health | Series B | $20.5M | — |
Top Co-Investors
Optum Ventures4 shared
Abingworth LLP3 shared
Catalys Pacific2 shared
F-Prime Capital2 shared
Fidelity Investments2 shared
SymBiosis2 shared
Designer Fund2 shared
Max Ventures2 shared
.406 Ventures2 shared
Kindred Ventures2 shared
Lerer Hippeau2 shared
LRVHealth2 shared
Health Velocity Capital2 shared
Martin Ventures2 shared
Flare Capital Partners2 shared
Impact Engine1 shared
Salesforce Ventures1 shared
7wire Ventures1 shared
Magnetic1 shared
Last updated: 27 September 2026